From: Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data
Genea | OS | DFS | ||
---|---|---|---|---|
HR (95% CI) | P valueb | HR (95% CI) | P valueb | |
SLC2A1 | 1.13 (0.91–1.39) | 0.271 | 1.28 (1.04–1.57) | 0.018 |
SLC2A2 | 0.82 (0.61–1.09) | 0.169 | 0.99 (0.8–1.24) | 0.957 |
SLC2A3 | 1.33 (1.06–1.66) | 0.013 | 1.32 (1.06–1.64) | 0.014 |
SLC2A4 | 1.12 (0.9–1.39) | 0.302 | 1.02 (0.82–1.27) | 0.864 |
SLC2A5 | 1.17 (0.94–1.47) | 0.159 | 1.04 (0.84–1.29) | 0.703 |
SLC2A6 | 1.24 (1–1.54) | 0.048 | 1.07 (0.87–1.32) | 0.503 |
SLC2A7 | 1.23 (1.03–1.46) | 0.019 | 1.06 (0.87–1.29) | 0.562 |
SLC2A8 | 0.82 (0.67–1.01) | 0.066 | 0.95 (0.78–1.17) | 0.646 |
SLC2A9 | 0.86 (0.7–1.05) | 0.135 | 1.00 (0.82–1.23) | 0.965 |
SLC2A10 | 0.94 (0.76–1.17) | 0.597 | 1.02 (0.82–1.27) | 0.876 |
SLC2A11 | 1.14 (0.9–1.43) | 0.277 | 1.11 (0.88–1.4) | 0.369 |
SLC2A12 | 1.05 (0.84–1.32) | 0.643 | 1.06 (0.86–1.32) | 0.574 |
SLC2A13 | 0.89 (0.71–1.11) | 0.305 | 1.02 (0.82–1.27) | 0.835 |
SLC2A14 | 1.19 (0.96–1.49) | 0.115 | 1.18 (0.96–1.46) | 0.123 |